Apply to trial NCT07556107

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 4Drug trial

The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)

The VPT Safety Trial (VPS) compares two common antibiotic combinations to see how they affect the kidneys of patients in the hospital with serious infections. Both combinations are approved by the Food and Drug Administration (FDA). The goal is to help doctors know which combination is safer so they can make better choices for their patients.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening